Koenig Sheldon L. - Insider Non-Derivative Transactions at Esperion Therapeutics, Inc. (ESPR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 17, 2024, Koenig Sheldon L.'s relationship to Esperion Therapeutics, Inc. (ESPR) is Director,Officer (President and CEO), and currently has 752,266 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ESPR insiders.
Data Source: SEC.
Koenig Sheldon L. - Insider Non-Derivative Transactions of ESPR Common Stock
Koenig Sheldon L. - Insider Non-Derivative Transactions at ESPR
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 18, 2024 | Sell -- (Common Stock) | 14550 | 1.8 | 752266 |
| Mar 15, 2024 | Acquisition -- (Common Stock) | 454000 | 0 | 766816 |
| May 10, 2023 | P -- (Common Stock) | 20000 | 1.26 | 312816 |
| Mar 18, 2023 | Sell -- (Common Stock) | 6999 | 1.78 | 292816 |
| Mar 15, 2023 | Acquisition -- (Common Stock) | 105000 | 0 | 299815 |
| Mar 8, 2023 | Sell -- (Common Stock) | 5441 | 5.06 | 194815 |